Continuous cardiac monitoring, provided by devices like Holter monitors, is crucial for early detection, management, and prevention of these conditions. These devices allow healthcare providers to ...

Thirty day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking science presented ...

LONDON--(BUSINESS WIRE)--The global Holter monitor market is poised to grow by USD 176.83 million during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Request free sample ...

Philips announced a national partnership with Optum Healthcare to provide access to its Mobile Cardiac Telemetry (MCOT) and ...

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition affecting about 1 in 500 people and is one of the leading causes of sudden cardiac death (SCD) in people under 35, including among ...

Report Ocean has published a new report on the ECG Patch & Holter Monitor Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report ...

SAN FRANCISCO, May 18, 2017 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced ...

VitalConnect announced the launch of its AI-based continuous remote cardiac monitoring solution for patients who require extended Holter monitoring. The new system (VitalPatch RTM, VitalConnect) ...

Researchers have discovered that a small adhesive wireless device worn on the chest for up to two weeks does a better job detecting abnormal and potentially dangerous heart rhythms than the Holter ...